Activity Available: December 5, 2023 – August 1, 2024
Education Activity Description: Experience select presentations on-demand from the diverse scientific program of AAIC 2023. Immerse yourself in cutting-edge content while earning continuing education credit.
Jointly provided by Postgraduate Institute for Medicine and Alzheimer’s Association
Estimated time to complete activity: Approximately 1 hour and 15 minutes per module (1.25 Credits)
- Utilize advances in technology to improve diagnosis and monitor disease progression
- Compare the pathophysiology of aging, Alzheimer's disease and other geriatric syndromes
- Identify potential targets for treatment of Alzheimer's disease
- Discuss recommendations for the prevention of Alzheimer's disease
- Explain therapeutic breakthroughs in neurodegenerative disease
- Identify emerging strategies likely to drive future advances in Alzheimer’s disease
- Indicate how Alzheimer's disease affects society as it relates to health economics
Education and Faculty Disclosure Information (*Some data presented may be preliminary)
For questions, contact: firstname.lastname@example.org.
Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Target Audience: This activity is intended to meet the educational needs of primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.
Statement of Purpose: A practice gap is the difference between what healthcare professionals should or could be doing and what they are currently doing. Using current evidence based to bridge the gap between patient care and care recommendation, ensuring healthcare professionals are not only aware of current practice but are utilizing them in patient care settings. This will be accomplished by increasing awareness and knowledge of new guidelines on the impact that physical activity, diabetes and obesity, vascular risk, and tobacco use can have on brain health/cognition.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Alzheimer's Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education; The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™ per presentation. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 contact hours per presentation. This activity is being presented without bias and without commercial support.
Psychologist Continuing Education PIM is approved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibility for this program and its content. This program offers 1.25 continuing education credits for psychologists per presentation.
Continuing Pharmacy Education Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education.